FDA Inspection 1114827 — Seattle Women's Health, Research, Gynecology
The FDA completed an inspection of Seattle Women's Health, Research, Gynecology on December 9, 2019 in Seattle, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 9, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Seattle, WA (United States)
Additional Details
Clinical BA/BE